According to Larimar Therapeutics's latest financial reports the company's current EPS (TTM) is -0,87ย โฌ. In 2022 the company made an earnings per share (EPS) of -1,46ย โฌ an increase over its 2021 EPS that were of -2,81ย โฌ.